Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesJul 22, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJul 21, 1999View HTMLDownload DOCDownload PDFDownload XLS
8-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange ActJul 15, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1/AAmended Registration statement for face-amount certificate companiesJun 14, 1999View HTMLDownload DOCDownload PDFDownload XLS
S-1Registration statement for face-amount certificate companiesMay 4, 1999View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information